{"id":21830,"date":"2021-09-24T07:31:04","date_gmt":"2021-09-24T11:31:04","guid":{"rendered":"https:\/\/www.ipoboutique.com\/blog\/?p=21830"},"modified":"2021-09-24T07:31:04","modified_gmt":"2021-09-24T11:31:04","slug":"pipeline-update-three-set-terms-handful-of-companies-file-for-ipo","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/pipeline-update-three-set-terms-handful-of-companies-file-for-ipo\/","title":{"rendered":"Pipeline Update: Three Set Terms; Handful of Companies file for IPO"},"content":{"rendered":"<p><!--more--><\/p>\n<p><span style=\"text-decoration: underline;\"><strong>NEW FILINGS<\/strong><\/span><\/p>\n<p>Company: FWD Group Holdings Limited<br \/>\nSymbol: FWD (NYSE)<br \/>\nDescription: They are a fast-growing and leading Pan-Asian life insurer with a customer-led, legacy-light and digital-first model.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriters: Morgan Stanley, Goldman Sachs, J.P. Morgan<br \/>\nCo-Manager(s): HSBC, CMB International<br \/>\nLink to Prospectus: Filed: 9-23-21<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Aris Water Solutions, Inc.<br \/>\nSymbol: ARIS (NYSE)<br \/>\nDescription: They are a leading, growth-oriented environmental infrastructure and solutions company that directly helps our customers reduce their water and carbon footprints.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriters: Goldman Sachs, Citigroup, JP Morgan, Wells Fargo, Barclays, Evercore ISI<br \/>\nCo-Manager(s): Capital One Securities, Johnson Rice &amp; Co., Raymond James, Stifel, U.S. Capital Advisors<br \/>\nLink to Prospectus: Filed: 9-23-21<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Lucid Diagnostics, Inc.<br \/>\nSymbol: LUCD (Nasdaq)<br \/>\nDescription: They are are a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma (EAC).<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriters: Cantor, Canaccord Genuity<br \/>\nCo-Manager(s): BTIG, Needham<br \/>\nLink to Prospectus: Filed: 9-22-21<br \/>\nListed Cash Raise: $57.5m<\/p>\n<p>Company: Yesway, Inc..<br \/>\nSymbol: YSWY (Nasdaq)<br \/>\nDescription: Yesway is one of the fastest-growing convenience store operators in the U.S., with 403 Company-operated stores as of June 30, 2021, up from 140 as of December 31, 2018.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriters: Morgan Stanley, J.P. Morgan, Goldman Sachs, BMO Capital Markets, Barclays<br \/>\nLink to Prospectus: Filed: 9-21-21<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Enfusion, Inc..<br \/>\nSymbol: ENFN (NYSE)<br \/>\nDescription: Enfusion is a global, high-growth software-as-a-service, or SaaS, provider focused on transforming the investment management industry.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriters: Morgan Stanley, Goldman Sachs, BofA Securities, Credit Suisse<br \/>\nCo-Manager(s): Piper Sandler, Stifel, William Blair<br \/>\nLink to Prospectus: Filed: 9-17-21<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Pyxis Oncology, Inc.<br \/>\nSymbol: PYXO(Nasdaq)<br \/>\nDescription: They are a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriters: BofA Securities, Jefferies, Credit Suisse, William Blair<br \/>\nCo-Manager(s): LifeSci Capital<br \/>\nLink to Prospectus: Filed: 9-17-21<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: AvidXchange Holdings, Inc.<br \/>\nSymbol: AVDX (Nasdaq)<br \/>\nDescription: They are a leading provider of accounts payable, or AP, automation software and payment solutions for middle market businesses and their suppliers.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriters: Goldman Sachs, J.P. Morgan, BofA Securities, Barclays, Credit Suisse, KeyBanc Capital, Deutsche Bank, Piper Sandler<br \/>\nCo-Manager(s): Nomura, Fifth Third Securities<br \/>\nLink to Prospectus: Filed: 9-17-21<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Intuity Medical, Inc.<br \/>\nSymbol: POGO (Nasdaq)<br \/>\nDescription: They are a commercial-stage medical technology and digital health company focused on developing comprehensive solutions to improve the health and quality of life of people with diabetes.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriters: Goldman Sachs, Jefferies, Piper Sandler<br \/>\nCo-Manager(s): Raymond James<br \/>\nLink to Prospectus: Filed: 9-17-21<br \/>\nListed Cash Raise: $75m<\/p>\n<p>Company: Intermedia Cloud Communications, Inc.<br \/>\nSymbol: INTM<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nDescription: They provide a leading, proprietary cloud-based communications and collaboration platform, purpose-built for our extensive and expanding network of more than 7,000 channel partners and used by a growing base of over 122,000 business customers as of December 31, 2020.<br \/>\nUnderwriter(s): Morgan Stanley, JP Morgan, Credit Suisse, Evercore ISI, Jefferies<br \/>\nCo-Manager(s): William Blair, KeyBanc Capital, TD Securities, Stephens, Loop Capital<br \/>\nLink to Prospectus: Filed: 9-17-21<br \/>\nListed Cash Raise: $100m<br \/>\nNote: IPO was Postponed in March 2021<\/p>\n<p>Company: AEON Biopharma, Inc<br \/>\nSymbol: AEON (Nasdaq)<br \/>\nDescription: They are a clinical stage biopharmaceutical company focused on developing our proprietary botulinum toxin complex, ABP-450 (prabotulinumtoxinA) injection, or ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriters: Wells Fargo, Cantor, Mizuho Securities<br \/>\nCo-Manager(s): HC Wainwright<br \/>\nLink to Prospectus: Filed: 9-17-21<br \/>\nListed Cash Raise: $75m<\/p>\n<p>Company: GitLab Inc.<br \/>\nSymbol: GTLB (Nasdaq)<br \/>\nDescription: They pioneered The DevOps Platform, a fundamentally new approach to DevOps consisting of a single codebase and interface with a unified data model.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriters: Goldman Sachs, J.P. Morgan, BofA Securities<br \/>\nCo-Manager(s): UBS Investment Bank, RBC Capital, Truist Securities, Piper Sandler, Cowen, KeyBanc Capital, William Blair<br \/>\nLink to Prospectus: Filed: 9-17-21<br \/>\nListed Cash Raise: $100m<\/p>\n<p><span style=\"text-decoration: underline;\"><strong>UPDATED TERMS<\/strong><\/span><\/p>\n<p>Company: First Watch Restaurant Group, Inc.<br \/>\nSymbol: FWRG (Nasdaq)<br \/>\nDescription: They are an award-winning daytime restaurant concept serving made-to-order breakfast, brunch and lunch using fresh ingredients.<br \/>\nShares: 9.459 million<br \/>\nPrice Range: $17.00-$20.00<br \/>\nMarket Cap: $1.0b-$1.15b<br \/>\nTrade Date: Friday, 10\/1<br \/>\nUnderwriters: BofA Securities, Goldman Sachs, Jefferies, Barclays, Citigroup, Piper Sandler, Cowen, Guggenheim Securities, Stifel<br \/>\nLink to Prospectus: Terms Added: 9-22-21<\/p>\n<p>Company: Allvue Systems Holdings Inc.<br \/>\nSymbol: ALVU<br \/>\nDescription: Allvue sets a new standard in technology for investment managers in the private capital and credit markets by pairing modern cloud-based software solutions with capabilities across multiple asset classes.<br \/>\nShares: 15.3 million<br \/>\nPrice Range: $17.00-$19.00<br \/>\nMarket Cap: $1.5b-$1.7b<br \/>\nTrade Date: Wednesday, 9\/29<br \/>\nUnderwriters: Goldman Sachs, Barclays, Credit Suisse, Deutsche Bank, RBC Capital, Truist Securities<br \/>\nCo-Manager(s): Piper Sandler, Stifel, Cabrera Capital Markets, CastleOak Securities, C.L. King &amp; Associates, Mischler Financial Group, Telsey Advisory Group<br \/>\nLink to Prospectus: Terms Added: 9-20-21<\/p>\n<p>Company: Olaplex Holdings Inc.<br \/>\nSymbol: OLPX (Nasdaq)<br \/>\nDescription: They are an innovative, science-enabled, technology-driven beauty company.<br \/>\nShares: 67 million<br \/>\nPrice Range: $14.00-$16.00<br \/>\nMarket Cap: $9.1b-$10.4b<br \/>\nTrade Date: Thursday, 9\/30<br \/>\nUnderwriters: Goldman Sachs, JP Morgan, Morgan Stanley, Barclays, BofA Securities, Evercore ISI, Jefferies, Raymond James<br \/>\nCo Managers: Cowen, Piper Sandler, Truist Securities, Telsey Advisory Group, Drexel Hamilton, Loop Capital Markets<br \/>\nLink to Prospectus:Terms Added: 9-20-21<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":12986,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[2058,1536],"tags":[],"class_list":["post-21830","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-spotlight","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/21830","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=21830"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/21830\/revisions"}],"predecessor-version":[{"id":21831,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/21830\/revisions\/21831"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media\/12986"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=21830"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=21830"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=21830"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}